Catherine Pearce - Jan 6, 2022 Form 4 Insider Report for CinCor Pharma, Inc. (CINC)

Role
Chief Operating Officer
Signature
/s/ Cathy Rude, Attorney-in-Fact
Stock symbol
CINC
Transactions as of
Jan 6, 2022
Transactions value $
$0
Form type
4
Date filed
1/10/2022, 03:19 PM
Next filing
Jan 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CINC Restricted Stock Units Award $0 +26.5K $0.00 26.5K Jan 6, 2022 Common Stock 26.5K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
F2 The RSUs vest in two equal annual installments beginning January 11, 2023, subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.